BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6239685)

  • 1. Deficient expression of class-I HLA in some cases of acute leukemia.
    Elkins WL; Pickard A; Pierson GR
    Cancer Immunol Immunother; 1984; 18(2):91-100. PubMed ID: 6239685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells.
    Sosman JA; Oettel KR; Smith SD; Hank JA; Fisch P; Sondel PM
    Blood; 1990 May; 75(10):2005-16. PubMed ID: 1692492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to human cell surface antigens.
    Brown G; Joshua DE; Bastin J; Mason DY; Barnstable CJ
    Haematol Blood Transfus; 1979; 23():365-8. PubMed ID: 296113
    [No Abstract]   [Full Text] [Related]  

  • 4. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
    Navarrete C; Fernandez N; Alonso MC; Festenstein H
    Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.
    Mutis T; Schrama E; Melief CJ; Goulmy E
    Blood; 1998 Sep; 92(5):1677-84. PubMed ID: 9716596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS; Storb R; Weiden PL; Thomas ED
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytotoxic antibodies in leukemic patients treated with bone marrow transplantation.
    Lawler SD; Jones EH; Jackson S; Powles RL
    Transplantation; 1985 Mar; 39(3):263-5. PubMed ID: 2579491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elicitation of anti-leukemia cytotoxic responses.
    Bach FH; Sondel PM; Zarling JM
    Haematol Blood Transfus; 1979; 23():369-76. PubMed ID: 161756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 125I-protein A-binding assay detecting antibodies to cell surface antigens. Evidence for the presence of specific antibodies against leukemia-associated antigens in human leukemias.
    Fäldt R; Ankerst J
    Cancer Immunol Immunother; 1983; 15(2):69-77. PubMed ID: 6223693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
    Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
    Blood; 1993 Apr; 81(8):2200-8. PubMed ID: 8471780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
    Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
    Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation.
    Chan KW; Pollack MS; Braun D; O'Reilly RJ; Dupont B
    Transplantation; 1982 Jun; 33(6):613-5. PubMed ID: 6954756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA associations with leukemia.
    Bortin MM; D'Amaro J; Bach FH; Rimm AA; van Rood JJ
    Blood; 1987 Jul; 70(1):227-32. PubMed ID: 3474040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific recognition of human leukemic cells by allogeneic T cell lines.
    Sosman JA; Oettel KR; Hank JA; Fisch P; Sondel PM
    Transplantation; 1989 Sep; 48(3):486-95. PubMed ID: 2571206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA typing of leukemic cells and lymphoblastoid cell lines: effects of non-HLA antibodies in common typing sera.
    DuBois D; Specian TL; Pollack MS
    Prog Clin Biol Res; 1977; 16():115-28. PubMed ID: 269454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune reactions to human leukemia.
    Herberman RB; Rosenberg EB; Halterman RH; McCoy JL; Leventhal BG
    Natl Cancer Inst Monogr; 1972 Dec; 35():259-66. PubMed ID: 4266905
    [No Abstract]   [Full Text] [Related]  

  • 18. Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the "graft versus leukemia" effect.
    Sondel PM; Hank JA; Molenda J; Blank J; Borcherding W; Longo W; Trigg ME; Hong R; Bozdech MJ
    Exp Hematol; 1985 Sep; 13(8):782-90. PubMed ID: 2931298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells.
    Hoffmann T; Theobald M; Bunjes D; Weiss M; Heimpel H; Heit W
    Bone Marrow Transplant; 1993 Jul; 12(1):1-8. PubMed ID: 8374531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.
    Sondel PM; O'Brien C; Porter L; Schlossman SF; Chess L
    J Immunol; 1976 Dec; 117(6):2197-203. PubMed ID: 1069027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.